Biotech

All Articles

Lilly, Haya ink $1B biobuck being overweight treaty to search black genome

.Eli Lilly's search for obesity aim ats has actually led it to the black genome. The Big Pharma has ...

ArsenalBio increases $325M, pivots off of previous lead property

.Collection Biosciences is going on up. The cell treatment business has added $325 million in ammuni...

Lilly- supported fat burning biotech data IPO

.After elevating $170 thousand back in February, metabolic disease-focused BioAge Labs has actually ...

Aelis' marijuana use medication flunks period 2b, steering Indivior to review $100M possibility

.Aelis Farma's chances of protecting a simple, beneficial choice on a $100 thousand alternative repa...

ProKidney halts period 3 trial certainly not required for tissue therapy approval

.ProKidney has actually ceased some of a set of period 3 trials for its cell therapy for renal illne...

Vaxcyte rises on 'impressive' 31-valent PCV succeed against Pfizer

.Vaxcyte introduced what analysts named "stunning" period 1/2 data for its 31-valent pneumococcal va...

Recursion's brain health condition test reveals insufficient evidence of efficacy

.Recursion has actually discovered through an early exam of its tech-enabled strategy to medicine re...

Acepodia, Pfizer click together for chemistry-based cell therapy

.Contact it a scenario of great chemical make up: Acepodia, a biotech based upon Nobel Champion scie...

Praxis epilepsy medication lowers confiscations in period 2 litigation

.Praxis Preciseness Medicines has scored an additional midphase succeed in epilepsy this year, with ...

Three officers resign as Dyne posts blended data for DMD prospect

.After escaping a clinical grip several years back, Dyne Therapeutics has actually disclosed brand-n...